Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/18374
Title: Chemoimmunotherapy May Not Be Dead Yet in Chronic Lymphocytic Leukemia, But Fludarabine Plus Cyclophosphamide Plus Rituximab Is Potentially Facing Life Support.
Authors: Opat, Stephen;Hawkes, Eliza A
Affiliation: Austin Health, Heidelberg, Victoria, Australia
Monash University, Melbourne, Australia
Monash Health, Clayton, Australia
Eastern Health, Box Hill, Australia
Issue Date: 20-Dec-2017
EDate: 2017-11-03
Citation: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017; 35(36): 4093-4094
URI: http://ahro.austin.org.au/austinjspui/handle/1/18374
DOI: 10.1200/JCO.2017.75.4721
PubMed URL: 29099632
Type: Journal Article
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.